Navigation Links
US Senate Votes against Testing of Pesticide on Humans

The US congress is considering whether to temporarily ban the Environmental Protection Agency (EPA) from using human tests to determine whether a pesticide should be marketed//. Lawmakers on Capitol Hill will soon decide whether to place a one year moratorium on the conduct and use of studies that expose participants to pesticides. In most cases, trials are conducted by companies seeking to have their pesticides approved by the agency for marketing.

The Republican controlled US senate voted 60 to 37 to enact, such a moratorium, in an amendment to the spending bill that funds the EPA. The amendment would prohibit the agency, beginning on 1 October, from conducting human exposure tests or using data from tests conducted by third parties in its pesticide risk assessments. An identical amendment was passed by the House in May.

The Pesticide companies became interested in human testing seemingly in a bid to circumvent a 1996 law that made it more difficult to use animal tests to meet agency standards for protecting vulnerable populations such as children from pesticide residues. The EPA now considers human testing data on a case by case basis, rejecting only experiments deemed scientifically unsound or ‘fundamentally unethical’ by EPA staff.

“The moral and ethical issues surrounding these pesticide experiments are overwhelming,” California Democratic Senator Barbara Boxer, who introduced the amendment, said after the vote. The Pesticide industry, represented by the Washington lobbying group CropLife America, adds that it is ‘troubled by the blatant manipulation of the facts’ by Democratic senators. “Sound science and public health protections have affirmed the safety and ethics of human data studies,’ the group said in its statement.

An alternative amendment, sponsored by Republican Senator Conrad Burns, also passed the senate by a vote of 57 to 40. That version would allow the EPA to use third party human tests in licensin g decisions, within careful constraints. Unlike the Boxer amendment, it does not prohibit the EPA from conducting its own tests. A joint House Senate committee is expected this summer to determine which version prevails.

(Source: Nature Medcine)
'"/>




Related medicine news :

1. Senate assures ban on smoking
2. US Senate Approves Embryo-research Plan Despite Presidents Refusal
3. Senate Committee Approves Telemedicine Mental Health Bill
4. US Senate Passes Stem Cell Research Bill
5. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
6. Man against HIV – new vaccine ready for human trials
7. Antibiotics losing their power against acne
8. South Africa Wins landmark case against pharmaceutical giants
9. Vitamin E, the latest warrior against diabetes
10. Acne may protect against infections
11. Fight against E.coli
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... telemedicine solutions, has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable ... is an extension to RMT technology that delivers HD, dynamic, streaming ultrasound images ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth ... this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present ... the clinic’s leading recovery program. , “We know it’s easy to get ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... Clinical Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly integrate ... information has been condensed to a single page, maximizing usability and improving efficiency ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: